Paul McClintock to chair new Metlifecare board

Metlifecare is pleased to welcome its new owner, Swedish investment firm EQT, from today.

Metlifecare chief executive Glen Sowry said the transition to private ownership marks an important and positive milestone for the company.

“EQT has significant experience in health and aged care and, from the outset, was attracted to Metlifecare’s reputation for outstanding resident care. The company’s development programme is entering an exciting new phase with several new villages under construction and we look forward to accelerating this growth in this next phase of our 35-year history.”

Following the purchase, EQT has appointed a new board for Metlifecare who bring a wealth of expertise and experience in health and aged care, public policy, development, and governance.

The board will be chaired by Paul McClintock AO who has extensive health and aged care experience, and formerly acted as secretary to Cabinet and head of the Cabinet Policy Unit under Australian prime minister, John Howard.

The other directors are Dr Jonathan Coleman, Ken Lotu-Iiga, Maggie Owens, and Murray Jordan.

Incoming chair McClintock said: “The new board members bring a wealth of experience that will be relevant to the long-term value creation of the business and focus on ensuring Metlifecare continues to be a retirement village and aged care provider of choice.”

Ken Wong, who will also serve on the board and is the head of EQT Australia and New Zealand, said: “Consistent with EQT’s global approach to governance, Metlifecare’s board will bring significant relevant industry expertise to support the business and management through this next phase of the company’s growth.”

Board of Metlifecare biographies:

• Paul McClintock AO is chair of St Vincent’s Health, Australia’s largest not-for-profit hospital and aged care operator, I-MED Radiology, and Laser Clinics Australia. McClintock has chaired a number of healthcare-related companies including Medibank, Affinity Health, Central Sydney Area Health, Sydney Health Partners and the Woolcock Institute for Respiratory Medicine.
• Dr Jonathan Coleman is a director of Acurity Health Group. Prior to this he was chief executive of Acurity for two years. He was a Member of the New Zealand Parliament for 12 years, serving as a Cabinet minister in the John Key/Bill English governments for nine of those years. He was minister of health from 2014 to 2017. Coleman holds a medical degree from Auckland University and an MBA from the London Business School, and worked as a doctor and management consultant in New Zealand, UK and Australia.
• Ken Lotu-Iiga is a programme director at Kāinga Ora, the government’s housing agency. Lotu-Iiga has significant experience in the New Zealand building, construction and development sectors, including 25 years at Fletcher Building and its predecessor companies. Lotu-Iiga is also a director of the Cancer Society and on the board of trustees at Auckland Grammar School.
• Maggie Owens was most recently an operational director for Bupa New Zealand. Owens held a variety of roles during her 11-year tenure at Bupa, including director of independent living and acting chief operating officer for 14 months. She is past president of the Retirement Villages Association working in the retirement living and aged care sector for more than 30 years and began her career as a registered nurse.
• Murray Jordan is a director of Chorus, Metcash, SkyCity, Southern Cross Medical Care Society, Southern Cross Hospitals, Stevenson Group and the Starship Foundation. Previously he was the managing director of Foodstuffs North Island. Prior to that role, Jordan was GM of sales and performance and property strategy for Foodstuffs, and of AMP’s New Zealand unlisted property portfolio.
• Ken Wong is a managing director at EQT and Head of EQT Australia & New Zealand.

Sowry said it was encouraging to see the calibre, depth and range of experience of the new Board members. “The combination of strong experience in clinical and health, and development and property, will be invaluable to support our growth ambitions and accelerate innovation at Metlifecare.”

This is supplied content and not commissioned or paid for by NBR.